Copyright
©The Author(s) 2023.
World J Gastroenterol. May 14, 2023; 29(18): 2875-2887
Published online May 14, 2023. doi: 10.3748/wjg.v29.i18.2875
Published online May 14, 2023. doi: 10.3748/wjg.v29.i18.2875
Table 3 The different skeletal muscle abnormalities in patients
| Skeletal muscle abnormalities (n = 108) | PMA | ||
| Low (n = 35); BMI < 25 kg/m2: < 41 HU; BMI ≥ 25 kg/m2: < 33 HU | Normal (n = 73); BMI < 25 kg/m2: ≥ 41 HU; BMI ≥ 25 kg/m2: ≥ 33 HU | ||
| TPMT | Low (n = 31); Male: < 10.7 mm/m; Female: < 7.8 mm/m | Sarcopenia; Myosteatosis; (n = 15) | Sarcopenia; No myosteatosis; (n = 14) |
| Normal (n = 77); Male: ≥ 10.7 mm/m; Female: ≥ 7.8 mm/m | Myosteatosis; No sarcopenia; (n = 20) | No myosteatosis; No sarcopenia; (n = 59) | |
- Citation: Yin L, Chu SL, Lv WF, Zhou CZ, Liu KC, Zhu YJ, Zhang WY, Wang CX, Zhang YH, Lu D, Cheng DL. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2023; 29(18): 2875-2887
- URL: https://www.wjgnet.com/1007-9327/full/v29/i18/2875.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i18.2875